Real-time cough measurement at scale

“Overall, Hyfe’s technology has been robust, accurate, and user-friendly for both participants and study staff. Communication with the Hyfe team - including data science, clinical operations, and technical support - has been timely and solution-oriented. We are pleased with the data quality and the overall collaboration.”

“Hyfe’s team is excellent. They are responsive and collaborative and their technology performed reliably in a real-world chronic bronchitis population. The accuracy of cough detection, clarity of dashboards, and availability of Hyfe’s support contributed to a smooth study experience. We are satisfied with the partnership and confident in continuing with Hyfe’s platform in future trials.”

“I believe that this technology has a plethora of potential applications in the field of respiratory medicine, in both research and clinical practice.”

“In the end, cough could become something clinicians use to ensure their patient is fine, the treatment is working, and there is no exacerbation. We can generate reliable data, and we see value in long-term clinical management.”

“It seems absurd in this day and age for us to assess patients every three months when they are receiving medications that could probably be reduced in a week or two if there was adequate monitoring outside of the formal clinic setting. … The application of cough monitoring in sarcoidosis will allow for an earlier reduction in toxic medications as well as earlier evaluation of pulmonary sarcoidosis exacerbations… I don’t see why a similar treatment paradigm couldn’t be developed for other more common respiratory diseases.”

“I find Hyfe’s work so compelling. I want to understand whether we can document cough frequency in patients with heart failure and use it as an early indicator of fluid accumulation in the lungs. If we could detect increased coughing, especially while lying down, as an early sign of decompensation, it could transform heart failure management.”